09 Jun Ken Brijlall Joins Qmetis as Director of Technology and Innovation
NEW YORK, NY (June 8th, 2020) – Qmetis Inc, a healthcare technology company that builds clinical decision-support tools based on the science of evidence-based medicine, announced today that Ken Brijlall has joined the Company as Director of Technology and Innovation in the company’s New York Office.
Ken, previously a senior-level technology consultant at HSBC, brings over a decade of experience in technology management and product development to Qmetis. His project management skills, technical background, and MBA education from a top-ranked MBA program will support the short and long-term goals of Qmetis.
As a Director of Technology and Innovation Ken will not only be directing the development of new products for TBI, Stroke, Concussion and Hospital Acquired Infections but he will also be managing the QFutures division of Qmetis to focus on long-term strategy, future product development, innovation, and international expansion in Europe and Asia.